News
An advisor to the Department of Health told MPs a ‘Plan C’ has been mentioned in Government discussions, should the surge in COVID cases worsen. No...
The MHRA has approved Quell Therapeutics’ first clinical trial for its lead cell therapy candidate QEL-001. This approval paves the way for the first...
A study conducted by Nature Medicine has revealed an increased risk of Guillain-Barre Syndrome (GBS) and Bell’s palsy following a first dose of...
The FDA and EMA have accepted Novartis’ Supplemental Biologics License Application (sBLA) and Type II Variation for KymriahⓇ in patients with...
The National Institute for Health research has awarded funding to the University of Oxford, working with several other UK universities, to carry out...
The EMA’s human medicine’s committee (CHMP) has initiated a rolling review of the investigational antiviral drug molnupiravir for the treatment of...
As the NHS faces soaring waiting lists and prepares for a winter surge in COVID cases, they must also gear up for another potential crisis: medicine...
The MHRA has granted a licence for Ryeqo (a relugolix combination therapy), for the treatment of moderate to severe symptoms of uterine fibroids in...
Infectious disease expert, Dr Anthony Fauci, has said that COVID-19 vaccines for children aged 5-11 could be available by early November, in light of...
More people self-funding routine operations as NHS waiting lists hit record levelsNew data from the Private Healthcare Information Network (PHIN)...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
